Italia markets open in 6 hours 10 minutes

Dow Jones
38.686,32
+574,82(+1,51%)
Nasdaq
16.735,02
-2,08(-0,01%)
Nikkei 225
38.970,27
+482,37(+1,25%)
EUR/USD
1,0858
+0,0004(+0,03%)
Bitcoin EUR
62.354,22
-64,86(-0,10%)
CMC Crypto 200
1.462,47
+33,90(+2,37%)

NVCR Jan 2025 15.000 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

1,6500

0,0000

(0,00%)

In data: 01:53PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in